Vagus nerve stimulation in autoimmune conditions: a systematic review
Lombo LE, Tejada‐Perdomo JH, Ramos‐Castaneda JA, Garcia RG
ACR Open Rheumatology · 2025
Key finding
Across 12 clinical trials of VNS in autoimmune conditions, more than half found reductions in pro-inflammatory cytokines, with IL-6 most consistently reduced (6 of 7 studies).
- Condition
- InflammationGut Health
- Stimulation
- iVNS
- Evidence tier
- Systematic Review / Meta-Analysis
- Participants
- —
Cite this study
Lombo, L. E., Tejada‐Perdomo, J. H., Ramos‐Castaneda, J. A., & Garcia, R. G. (2025). Vagus nerve stimulation in autoimmune conditions: a systematic review. ACR Open Rheumatology, 7(12). https://doi.org/10.1002/acr2.70137
Related studies in Inflammation
No consistent evidence for the anti-inflammatory effect of vagus nerve stimulation in humans: a systematic review and meta-analysis
Schiweck et al. · Brain, Behavior, and Immunity · 2024 · Systematic Review / Meta-Analysis
Transcutaneous vagus nerve stimulation has no anti-inflammatory effect in diabetes
Okdahl et al. · Scientific Reports · 2024 · Randomised Controlled Trial
Noninvasive Vagus Nerve Stimulation in Postural Tachycardia Syndrome: A Randomized Clinical Trial
Stavrakis et al. · JACC. Clinical electrophysiology · 2024 · Randomised Controlled Trial
Transcutaneous vagal nerve stimulation blocks stress-induced activation of Interleukin-6 and interferon-gamma in posttraumatic stress disorder: A double-blind, randomized, sham-controlled trial
Bremner et al. · Brain, Behavior, & Immunity - Health · 2020 · Randomised Controlled Trial
Summary by Vagus Research. Always consult the primary source for the authoritative record.